University of Texas Health Science Center at Houston: Anti-Inflammatory Compound Shows Potential in Treating Patients With Severe COVID-19
July 21, 2022
July 21, 2022
HOUSTON, Texas, July 21 (TNSjou) -- The University of Texas Health Science Center at Houston issued the following news on July 20, 2022:
An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.
A team of researchers including UTHealth Houston faculty members Aaron M. Gusdon, M . . .
An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.
A team of researchers including UTHealth Houston faculty members Aaron M. Gusdon, M . . .